These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8657446)

  • 1. [Antidiabetogenic action of heparin during its oral administration].
    Ul'ianov AM; Tarasov IuA
    Patol Fiziol Eksp Ter; 1996; (1):21-3. PubMed ID: 8657446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Functional changes in the state of the insular system of animals after intravenous administration of diabetogenic factor].
    Kudriashov BA; Ul'ianov AM; Liapina LA
    Vopr Med Khim; 1986; 32(5):57-9. PubMed ID: 3535246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental analysis of the pathophysiological significance of the "diabetogenic factor" present in the blood of animals with alloxan diabetes].
    Baskakova GM; Kudriashov BA; Pytel' IuA
    Probl Endokrinol (Mosk); 1981; 27(4):42-5. PubMed ID: 7027248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intensification of the diabetogenic effect of alloxan by protamine sulfate].
    Kudriashov BA; Ul'ianov AM; Tarasov IuA
    Vopr Med Khim; 1989; 35(4):128-31. PubMed ID: 2815670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in the diabetogenic effect of alloxan in mice by treatment with the antineoplastic agent ICRF-187.
    El-Hage AN; Herman EH; Ferrans VJ
    Res Commun Chem Pathol Pharmacol; 1981 Sep; 33(3):509-23. PubMed ID: 7036302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-arginine and polyamine administration protect beta-cells against alloxan diabetogenic effect in Sprague-Dawley rats.
    Méndez JD; Hernández Rde H
    Biomed Pharmacother; 2005 Jul; 59(6):283-9. PubMed ID: 15996850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of endogenous heparin in the protection against risk factors causing experimental diabetes].
    Kudriashov BA; Ul'ianov AM; Tarasov IuA
    Vopr Med Khim; 1989; 35(6):80-2. PubMed ID: 2629244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prophylactic effect of vitamin A, neutralizing the development of experimental insulin-dependent diabetes in animals].
    Kudriashov BA; Ul'ianov AM; Tarasov IuA
    Vopr Med Khim; 1993; 39(1):20-2. PubMed ID: 8498064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective action of arachidonic acid against alloxan-induced cytotoxicity and diabetes mellitus.
    Suresh Y; Das UN
    Prostaglandins Leukot Essent Fatty Acids; 2001 Jan; 64(1):37-52. PubMed ID: 11161584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance of cats to the diabetogenic effect of alloxan.
    Hatchell DL; Reiser HJ; Bresnahan JF; Whitworth UG
    Lab Anim Sci; 1986 Feb; 36(1):37-40. PubMed ID: 3959532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
    Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
    Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidiabetic activity of Caesalpinia bonducella seed extracts in rats.
    Kannur DM; Hukkeri VI; Akki KS
    Fitoterapia; 2006 Dec; 77(7-8):546-9. PubMed ID: 16905279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetogenic factor in the blood plasma in diabetes mellitus].
    Kudriashov BA; Ponasenkova GV; Pytel' IuA
    Probl Endokrinol (Mosk); 1982; 28(5):61-4. PubMed ID: 7145885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The protective effect of the arginine-heparin complex under simulation of insulin-dependent diabetes].
    Ul'ianov AM; Obergan TIu; Shubina TA; Pastorova VE; Liapina LA
    Izv Akad Nauk Ser Biol; 2010; (1):109-14. PubMed ID: 20235435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of heparin combined with aspirin upon intragastric administration on the state of the insulin system in animals with alloxan diabetes].
    Ul'ianov AM; Tarasov IuA; Liapina LA
    Izv Akad Nauk Ser Biol; 1995; (3):372-5. PubMed ID: 7670355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of saturated, monounsaturated, and polyunsaturated fatty acids on alloxan-induced diabetes mellitus.
    Suresh Y; Das UN
    Prostaglandins Leukot Essent Fatty Acids; 2006 Mar; 74(3):199-213. PubMed ID: 16412622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against alloxan diabetes by low-dose 60Co gamma irradiation before alloxan administration.
    Takehara Y; Yamaoka K; Hiraki Y; Yoshioka T; Utsumi K
    Physiol Chem Phys Med NMR; 1995; 27(3):149-59. PubMed ID: 8868575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complex-formation of heparin with the plasma diabetogenic factor].
    Kudriashov BA; Liapina LA
    Vopr Med Khim; 1986; 32(2):64-5. PubMed ID: 3705518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoglycemic and antihyperglycemic effects of diethyl ether fraction isolated from the aqueous extract of the leaves of Cogniauxia podoleana Baillon in normal and alloxan-induced diabetic rats.
    Diatewa M; Samba CB; Assah TC; Abena AA
    J Ethnopharmacol; 2004 Jun; 92(2-3):229-32. PubMed ID: 15138005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoglycemic and antiperglycemic effects of Semecarpus anacardium linn in normal and alloxan-induced diabetic rats.
    Kothai R; Arul B; Kumar KS; Christina AJ
    J Herb Pharmacother; 2005; 5(2):49-56. PubMed ID: 16260409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.